R
Rigel Pharmaceuticals, Inc.
RIGL · NASDAQ · Healthcare · 788M
Closing price
$49.08
+0.74% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
2.4×
Price / net assetsP/B
2.3×
Enterprise value / EBITDAEV/EBITDA
6.8×
Free cash flow yieldFCF yield
8.6%
Return on equityROE
93.8%
Operating margin
42.6%
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
17.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.